Colin Fischbacher, Robert Milroy, D. Giannini, R. D. H. Monie
Abstract
The response to Duovent and salbutamol aerosols was compared in sixteen asthmatics in a double blind cross-over trial. Improvement in FEV1 was significantly better and longer lasting with Duovent . Side effects were not a major problem.
OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The response to Duovent and salbutamol aerosols was compared in sixteen asthmatics in a double blind cross-over trial. Improvement in FEV1 was significantly better and longer lasting with Duovent . Side effects were not a major problem.
Key concepts: Salbutamol, Medicine, Asthma, Bronchodilator Agents, Anesthesia, Double blind, Bronchodilator, Internal medicine